Yingfeng Lu
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 13
- SARS-CoV-2 and COVID-19 Research 6
-
- Hepatitis C virus research 4
- Co-authors
- Lanjuan Li (14 shared papers)Jifang Sheng (6 shared papers)Jiangshan Lian (15 shared papers)Chanyuan Ye (9 shared papers)Jueqing Gu (9 shared papers)Ciliang Jin (5 shared papers)Huan Qin Cai (6 shared papers)Jianhua Hu (6 shared papers)
- Journals
- Journal of Medical Virology (3 papers)Frontiers in Immunology (3 papers)Analytica Chimica Acta (2 papers)International Journal of Infectious Diseases (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yingfeng Lu
49 papers receiving 2.8k citations
Yingfeng Lu's Hit Papers
Peers
Comparison fields: 5 of 144
- Infectious Diseases 1.2k
- Neurology 586
- Biological Psychiatry 40
- Modeling and Simulation 66
- Critical Care and Intensive Care Medicine 50
Countries citing papers authored by Yingfeng Lu
This map shows the geographic impact of Yingfeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingfeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingfeng Lu more than expected).
Fields of papers citing papers by Yingfeng Lu
This network shows the impact of papers produced by Yingfeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingfeng Lu. The network helps show where Yingfeng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yingfeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms Hit paper breakdown → | 2020 | 1011 |
| 2 | 2020 | 261 | |
| 3 | 2020 | 234 | |
| 4 | 2018 | 212 | |
| 5 | 2021 | 101 | |
| 6 | 2015 | 72 | |
| 7 | 2020 | 71 | |
| 8 | 2014 | 70 | |
| 9 | 2021 | 65 | |
| 10 | 2018 | 63 | |
| 11 | 2020 | 54 | |
| 12 | 2020 | 47 | |
| 13 | 2021 | 46 | |
| 14 | 2020 | 44 | |
| 15 | 2020 | 42 | |
| 16 | 2020 | 41 | |
| 17 | 2019 | 40 | |
| 18 | 2020 | 36 | |
| 19 | 2023 | 31 | |
| 20 | 2015 | 29 |
About Yingfeng Lu
Yingfeng Lu is a scholar working on Infectious Diseases, Hepatology, Epidemiology, Cellular and Molecular Neuroscience and Neurology, having authored 53 papers that have together received 2.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (13 papers), Hepatitis B Virus Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Nerve injury and regeneration (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Long-Term Effects of COVID-19 (4 papers), Hepatitis C virus research (4 papers) and Gut microbiota and health (4 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Neurology (586 citations), Biological Psychiatry (40 citations), Modeling and Simulation (66 citations) and Critical Care and Intensive Care Medicine (50 citations). Yingfeng Lu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Lanjuan Li, Jifang Sheng, Jiangshan Lian, Chanyuan Ye, Jueqing Gu, Ciliang Jin, Huan Qin Cai, Jianhua Hu, Shanyan Zhang and Jian Wang. Their work appears in journals such as Journal of Medical Virology, Frontiers in Immunology, Analytica Chimica Acta, International Journal of Infectious Diseases and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.